{"disease":{"id":"opioid-dependence","name":"Opioid dependence","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":6,"pipeline_drug_count":0,"trial_count":1},"drugs":{"marketed":[{"drug_id":"buprenorphine-hydrochloride","indication_name":"Opioid dependence","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Subutex","generic_name":"Buprenorphine Hydrochloride","company_name":"Indivior","drug_phase":"marketed","molecular_target":"mu-opioid receptor, kappa-opioid receptor","drug_class":"partial opioid agonist","quality_score":75,"revenue":"800","mechanism":"Buprenorphine is a partial agonist at mu-opioid receptors and antagonist at kappa-opioid receptors."},{"drug_id":"buprenorphine","indication_name":"Opioid dependence","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Subutex","generic_name":"BUPRENORPHINE","company_name":"Purdue Pharma Lp","drug_phase":"marketed","molecular_target":"mu-opioid receptor, kappa-opioid receptor","drug_class":"Partial Opioid Agonist","quality_score":75,"revenue":"800","mechanism":"Buprenorphine binds to mu-opioid receptors as a partial agonist and kappa-opioid receptors as an antagonist."},{"drug_id":"buprenorphine","indication_name":"Opioid Dependence Treatment","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Subutex","generic_name":"BUPRENORPHINE","company_name":"Purdue Pharma Lp","drug_phase":"marketed","molecular_target":"mu-opioid receptor, kappa-opioid receptor","drug_class":"Partial Opioid Agonist","quality_score":75,"revenue":"800","mechanism":"Buprenorphine binds to mu-opioid receptors as a partial agonist and kappa-opioid receptors as an antagonist."},{"drug_id":"naloxone","indication_name":"Opioid dependence","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Narcan","generic_name":"NALOXONE","company_name":"Adapt","drug_phase":"marketed","molecular_target":"Mu-type opioid receptor","drug_class":"Opioid Antagonist","quality_score":60,"revenue":null,"mechanism":""},{"drug_id":"levomethadone","indication_name":"Opioid dependence","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"LEVOMETHADONE","company_name":"","drug_phase":"phase_2","molecular_target":"","drug_class":"levomethadone","quality_score":null,"revenue":null,"mechanism":"LEVOMETHADONE works by binding to opioid receptors in the brain, reducing withdrawal symptoms and cravings."},{"drug_id":"levomethadyl-acetate","indication_name":"Opioid dependence","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Orlaam","generic_name":"LEVOMETHADYL ACETATE","company_name":"Roxane","drug_phase":"marketed","molecular_target":"Potassium voltage-gated channel subfamily H member 2","drug_class":"High Risk QT Prolonging Agents","quality_score":45,"revenue":null,"mechanism":""},{"drug_id":"methadone","indication_name":"Temporary Treatment of Opioid Dependence","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Methadone Hydrochloride","generic_name":"METHADONE","company_name":"Specgx Llc","drug_phase":"marketed","molecular_target":"mu-opioid receptors, NMDA receptor","drug_class":"Opioid Agonist","quality_score":66,"revenue":null,"mechanism":"Methadone is a synthetic opioid that acts as a mu-agonist, providing analgesia and aiding in opioid addiction management."},{"drug_id":"acetylmethadol","indication_name":"Opioid dependence","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Methadyl","generic_name":"acetylmethadol","company_name":"","drug_phase":"unknown","molecular_target":"Mu-type opioid receptor","drug_class":"","quality_score":null,"revenue":null,"mechanism":"Methadyl works by blocking potassium channels in the brain to stabilize neuronal activity and reduce withdrawal symptoms."}],"pipeline":[],"offLabel":[],"totalMarketed":8,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07466784","title":"CEDRN: Opioid Registry","phase":"","overall_status":"RECRUITING","enrollment_count":7200,"lead_sponsor_name":"University of British Columbia","has_results":false},{"nct_id":"NCT05678036","title":"Effects on Mortality and Clinical Course of a Patient's Choice Model for Opioid Maintenance Treatment for Opioid Dependence - Evaluation of a System Enabling a Large Expansion of Treatment Providers and Treatment Access","phase":"","overall_status":"UNKNOWN","enrollment_count":2500,"lead_sponsor_name":"Region Skane","has_results":false},{"nct_id":"NCT05897788","title":"Text-Messaging Telehealth and Contingency Management for Opioid Use Disorder Treatment Engagement","phase":"NA","overall_status":"RECRUITING","enrollment_count":1808,"lead_sponsor_name":"University of Pennsylvania","has_results":false},{"nct_id":"NCT03134092","title":"The Life STORRIED Study","phase":"NA","overall_status":"COMPLETED","enrollment_count":1302,"lead_sponsor_name":"University of Pennsylvania","has_results":true},{"nct_id":"NCT06129916","title":"Assessing the Acceptability, Feasibility, Effectiveness and Cost-effectiveness of LADB","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":760,"lead_sponsor_name":"PATH","has_results":false},{"nct_id":"NCT05221866","title":"Efficiency And Quality In Post-Surgical Pain Therapy After Discharge","phase":"NA","overall_status":"COMPLETED","enrollment_count":711,"lead_sponsor_name":"University of Nebraska","has_results":true},{"nct_id":"NCT02357901","title":"Treatment Seeking Participants With Opioid Use Disorders Assessing Tolerability of Depot Injections of Buprenorphine","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":665,"lead_sponsor_name":"Indivior Inc.","has_results":true},{"nct_id":"NCT03684681","title":"The Navigator Trial","phase":"NA","overall_status":"COMPLETED","enrollment_count":650,"lead_sponsor_name":"Rhode Island Hospital","has_results":false},{"nct_id":"NCT04571619","title":"HOPE Consortium Trial to Reduce Pain and Opioid Use in Hemodialysis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":643,"lead_sponsor_name":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","has_results":true},{"nct_id":"NCT03923374","title":"Opioid Use Disorder in Pregnancy in Long-Term Maternal/Infant Outcomes","phase":"","overall_status":"RECRUITING","enrollment_count":600,"lead_sponsor_name":"Senthil Sadhasivam","has_results":false},{"nct_id":"NCT03089983","title":"Addiction, HIV and Tuberculosis in Malaysian Criminal Justice Settings","phase":"NA","overall_status":"COMPLETED","enrollment_count":316,"lead_sponsor_name":"Yale University","has_results":true},{"nct_id":"NCT04664062","title":"Comparing Home, Office, and Telehealth Induction for Medication Assisted Treatment for Opioid Use Disorder","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":303,"lead_sponsor_name":"University of Colorado, Denver","has_results":false},{"nct_id":"NCT06434818","title":"Enhanced Digital-Chemosensory-Based Olfactory Training for Remote Management of Substance Use Disorders","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"Evon Medics LLC","has_results":false},{"nct_id":"NCT03155906","title":"Integrated Treatment of Hepatitis C Virus Infection","phase":"NA","overall_status":"COMPLETED","enrollment_count":298,"lead_sponsor_name":"Haukeland University Hospital","has_results":false},{"nct_id":"NCT06574009","title":"Better Options for Chronic Cancer Pain","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":294,"lead_sponsor_name":"VA Office of Research and Development","has_results":false},{"nct_id":"NCT04811014","title":"Young Houston Emergency Opioid Engagement System","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":250,"lead_sponsor_name":"The University of Texas Health Science Center, Houston","has_results":false},{"nct_id":"NCT06415994","title":"Multimodal Fetal and Placental Imaging and Biomarkers of Clinical Outcomes in Opioid Use Disorder","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":250,"lead_sponsor_name":"Indiana University","has_results":false},{"nct_id":"NCT03422211","title":"A Prospective Assessment of Opioid Utilization Post-operatively in Sports Orthopaedic Surgeries","phase":"","overall_status":"COMPLETED","enrollment_count":223,"lead_sponsor_name":"St. Louis University","has_results":false},{"nct_id":"NCT02502175","title":"Comparing Opium Tincture (OT) With Methadone for Medication-assisted Treatment of Opioid Use Disorder","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":204,"lead_sponsor_name":"University of British Columbia","has_results":false},{"nct_id":"NCT04394559","title":"Prevention of Opioid Use Disorder After Surgery","phase":"NA","overall_status":"UNKNOWN","enrollment_count":204,"lead_sponsor_name":"Brigham and Women's Hospital","has_results":false},{"nct_id":"NCT04454645","title":"Intervening With Opioid-Dependent MothersMothers and Infants","phase":"NA","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"University of Delaware","has_results":false},{"nct_id":"NCT03656120","title":"A Study of Thienorphine Hydrochloride Tablets in Relapse Prevention Treatment of Opioid Dependence","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":180,"lead_sponsor_name":"Wei Hao","has_results":false},{"nct_id":"NCT03726476","title":"Expectations and Pain Control Advancement In surgeRy: The REPAIR Trial","phase":"NA","overall_status":"COMPLETED","enrollment_count":174,"lead_sponsor_name":"University of New Mexico","has_results":true},{"nct_id":"NCT02411357","title":"Improving Effective Contraceptive Use Among Opioid-maintained Women: Stage II","phase":"NA","overall_status":"COMPLETED","enrollment_count":138,"lead_sponsor_name":"University of Vermont","has_results":true},{"nct_id":"NCT03971097","title":"The Effect of Self-Forgiveness on Self-Stigma in Addiction.","phase":"NA","overall_status":"COMPLETED","enrollment_count":130,"lead_sponsor_name":"University of Pittsburgh","has_results":false},{"nct_id":"NCT05995873","title":"A Project to Test the Efficacy and Safety of An Innovative Treatment for Opiate Use Disorders.","phase":"NA","overall_status":"UNKNOWN","enrollment_count":130,"lead_sponsor_name":"MindLight, LLC","has_results":false},{"nct_id":"NCT03495388","title":"PG and PK of Oxycodone to Personalize Post-op Pain Management Following Surgery in Children","phase":"","overall_status":"COMPLETED","enrollment_count":129,"lead_sponsor_name":"Senthil Sadhasivam","has_results":false},{"nct_id":"NCT03718065","title":"Impact of Lofexidine on Stress, Craving and Opioid Use","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":112,"lead_sponsor_name":"Medical University of South Carolina","has_results":true},{"nct_id":"NCT03603158","title":"KCNH2 Polymorphisms on the QTc Interval in Kelantanese Malays Patients Receiving Methadone Maintenance Therapy (MMT)","phase":"","overall_status":"COMPLETED","enrollment_count":111,"lead_sponsor_name":"Universiti Sains Malaysia","has_results":false},{"nct_id":"NCT03809143","title":"Community Studies of Long Acting Buprenorphine (CoLAB)","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"The University of New South Wales","has_results":false},{"nct_id":"NCT03789214","title":"Medical Management of Sleep Disturbance During Opioid Tapering","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":90,"lead_sponsor_name":"Johns Hopkins University","has_results":true},{"nct_id":"NCT03611335","title":"A Pragmatic Trial of the Consult for Addiction Treatment and Care in Hospitals (CATCH) Model for Engaging Patients in Opioid Use Disorder Treatment","phase":"","overall_status":"COMPLETED","enrollment_count":90,"lead_sponsor_name":"NYU Langone Health","has_results":false},{"nct_id":"NCT04867382","title":"Comparing Two Training Methods for Opioid Wizard","phase":"NA","overall_status":"COMPLETED","enrollment_count":88,"lead_sponsor_name":"HealthPartners Institute","has_results":true},{"nct_id":"NCT04790201","title":"Friendship Bench Adaptation to Improve Mental Health & HIV Care Engagement Outcomes Among PLWH and PWID in Vietnam","phase":"NA","overall_status":"COMPLETED","enrollment_count":77,"lead_sponsor_name":"University of North Carolina, Chapel Hill","has_results":true},{"nct_id":"NCT03334903","title":"Gabapentin Regimens and Their Effects on Opioid Consumption","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":77,"lead_sponsor_name":"Brigham and Women's Hospital","has_results":true},{"nct_id":"NCT05829655","title":"Measuring Acute Drug Demand in Humans","phase":"EARLY_PHASE1","overall_status":"SUSPENDED","enrollment_count":75,"lead_sponsor_name":"University of Maryland, Baltimore","has_results":false},{"nct_id":"NCT04413552","title":"INDV-2000 First in Human","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":73,"lead_sponsor_name":"Indivior Inc.","has_results":true},{"nct_id":"NCT06837662","title":"The MOUD Plus Pilot: Counseling and Peer Support to Support Retention for Medically Complex Patients With Opioid Use Disorder Seen In Primary Care","phase":"NA","overall_status":"RECRUITING","enrollment_count":70,"lead_sponsor_name":"Oregon Health and Science University","has_results":false},{"nct_id":"NCT03576781","title":"Developing rTMS Treatment Strategies for Pain in Opiate Dependence","phase":"EARLY_PHASE1","overall_status":"COMPLETED","enrollment_count":70,"lead_sponsor_name":"Medical University of South Carolina","has_results":false},{"nct_id":"NCT03842137","title":"tDCS to Decrease Opioid Relapse (UG3)","phase":"NA","overall_status":"COMPLETED","enrollment_count":62,"lead_sponsor_name":"Butler Hospital","has_results":true},{"nct_id":"NCT03992079","title":"A Multimodal Enhanced Recovery Program in Anorectal Surgery","phase":"NA","overall_status":"TERMINATED","enrollment_count":60,"lead_sponsor_name":"Columbia University","has_results":false},{"nct_id":"NCT05463367","title":"Project 1 Aim 2, Adaptations of the Brain in Chronic Pain With Opioid Exposure","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":60,"lead_sponsor_name":"Northwestern University","has_results":false},{"nct_id":"NCT03604159","title":"XRB vs. SLB in Jail and at Re-entry: Pilot, Proof of Concept","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":52,"lead_sponsor_name":"NYU Langone Health","has_results":true},{"nct_id":"NCT05370326","title":"Feasibility and Preliminary Efficacy of an Opioid Stewardship Program in Hospitalized Patients With Chronic Pain","phase":"NA","overall_status":"COMPLETED","enrollment_count":52,"lead_sponsor_name":"Yale University","has_results":true},{"nct_id":"NCT04464421","title":"SMART Effectiveness Trial","phase":"NA","overall_status":"COMPLETED","enrollment_count":48,"lead_sponsor_name":"Karen Derefinko, PhD","has_results":true},{"nct_id":"NCT06808932","title":"VK4-116 Phase I Study With Food-Effect","phase":"PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":48,"lead_sponsor_name":"National Institute on Drug Abuse (NIDA)","has_results":false},{"nct_id":"NCT04325659","title":"An Innovative Intervention for OUD Treatment","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":46,"lead_sponsor_name":"Johns Hopkins University","has_results":false},{"nct_id":"NCT03567356","title":"Treatment of Opioid Use: Medication Adherence Therapy","phase":"NA","overall_status":"COMPLETED","enrollment_count":45,"lead_sponsor_name":"Potomac Health Foundations","has_results":false},{"nct_id":"NCT03575273","title":"The Impact of Methadone Maintenance Therapy on Food Reward Processing in Opioid Dependence","phase":"NA","overall_status":"COMPLETED","enrollment_count":45,"lead_sponsor_name":"Johns Hopkins University","has_results":false},{"nct_id":"NCT06008990","title":"Maternal Brain Imaging in Opioid Use Disorder","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":40,"lead_sponsor_name":"Indiana University","has_results":false}],"total":50},"guidelines":[{"drug_id":"buprenorphine-hydrochloride","guideline_body":"FDA label","recommendation":"Buprenorphine sublingual tablets is indicated for the treatment of opioid dependence and is preferred for induction.","line_of_therapy":"1L","evidence_grade":"A","guideline_year":null}],"source":"Drug Landscape verified database"}